Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma

Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer

(2010) Rachel Abbotts et al.   CANCER TREATMENT REVIEWS

Novel Small-Molecule Inhibitor of Apurinic/Apyrimidinic Endonuclease 1 Blocks Proliferation and Reduces Viability of Glioblastoma Cells

(2010) A. Bapat et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging

(2009) Omid Veiseh et al.   ADVANCED DRUG DELIVERY REVIEWS

Survival following treatment for intracranial ependymoma: a review

(2009) G. Tamburrini et al.   CHILDS NERVOUS SYSTEM

The genetic and epigenetic basis of ependymoma

(2009) Stephen C. Mack et al.   CHILDS NERVOUS SYSTEM

Ependymoma: An Update

(2009) Stergios Zacharoulis et al.   JOURNAL OF CHILD NEUROLOGY

Pediatric Ependymoma: Biological Perspectives

(2009) J.-P. Kilday et al.   MOLECULAR CANCER RESEARCH

The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme

(2008) Gianluca Tell et al.   ANTIOXIDANTS & REDOX SIGNALING

Pharmacophore Guided Discovery of Small-Molecule Human Apurinic/Apyrimidinic Endonuclease 1 Inhibitors

(2008) Zahrah Zawahir et al.   JOURNAL OF MEDICINAL CHEMISTRY

Incidence patterns for ependymoma: a Surveillance, Epidemiology, and End Results study

(2008) Courtney S. McGuire et al.   JOURNAL OF NEUROSURGERY

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma

(2008) Lee Ridley et al.   NEURO-ONCOLOGY